LEADER 04564nam 22007094a 450 001 9910458560203321 005 20200520144314.0 010 $a1-58901-355-7 035 $a(CKB)2560000000056448 035 $a(EBL)956369 035 $a(OCoLC)798536346 035 $a(SSID)ssj0000485428 035 $a(PQKBManifestationID)11344244 035 $a(PQKBTitleCode)TC0000485428 035 $a(PQKBWorkID)10603121 035 $a(PQKB)10555896 035 $a(SSID)ssj0001593430 035 $a(PQKBManifestationID)16290091 035 $a(PQKBTitleCode)TC0001593430 035 $a(PQKBWorkID)14880810 035 $a(PQKB)10989021 035 $a(MiAaPQ)EBC956369 035 $a(OCoLC)671571310 035 $a(MdBmJHUP)muse3253 035 $a(Au-PeEL)EBL956369 035 $a(CaPaEBR)ebr10408957 035 $a(EXLCZ)992560000000056448 100 $a20040930d2005 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aKidney for sale by owner$b[electronic resource] $ehuman organs, transplantation, and the market /$fMark J. Cherry 210 $aWashington, D.C. $cGeorgetown University Press$dc2005 215 $a1 online resource (273 p.) 300 $aDescription based upon print version of record. 311 $a1-62616-293-X 311 $a1-58901-040-X 320 $aIncludes bibliographical references and index. 327 $aCover; Contents; Acknowledgments; Introduction; ONE: HUMAN ORGAN SALES AND MORAL ARGUMENTS: THE BODY FOR BENEFICENCE AND PROFIT; Introduction; Challenges for Public Health Care Policy; "Global Consensus"; Prohibition: Controversies and Criticisms; TWO: METAPHYSICS, MORALITY, AND POLITICAL THEORY: THE PRESUPPOSITIONS OF PROSCRIPTION REEXAMINED; Introduction; Initial Considerations: Assessing Standards of Evidence and Placing the Burden of Proof; Persons and Body Parts; Owning One's Body; Repugnance: Adjudication among Moral Intuitions; Government, Health Care Policy, and Private Choices 327 $aSummaryTHREE: A MARKET IN HUMAN ORGANS: COSTS AND BENEFITS, VICES AND VIRTUES; Introduction; Health Care Costs and Benefits; Special Moral Costs and Benefits: Equality and Liberty; Exploitation: Organ Markets Verses Other Procurement and Allocation Strategies; Community, Altruism, and Free Choice; Scientific Excellence and the Marketplace; The Market and Profit: The Virtues and Vices of Free Choice; Summary; FOUR: THE BODY, ITS PARTS, AND THE MARKET: REVISIONIST INTERPRETATIONS FROM THE HISTORY OF PHILOSOPHY; Introduction; Major Theories; Summary; FIVE: PROHIBITION: MORE HARM THAN BENEFIT? 327 $aAspiring to an International BioethicsFalse Claims to Moral Consensus; Crafting Health Care Policy amid Moral Pluralism; Appendix: Sample of International Legislation Restricting the Sale of Human Organs for Transplantation; List of Cases; Notes; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; X; Y; Z 330 $aOver the past decade in the United States, nearly 6,000 people a year have died waiting for organ transplants. In 2003 alone, only 20,000 out of the 83,000 waiting for transplants received them--in anyone's eyes, a tragedy. Many of these deaths could have been prevented, and many more lives saved, were it not for the almost universal moral hand-wringing over the concept of selling human organs. Bioethicist Mark Cherry explores the why of these well-intentioned misperceptions and legislation and boldly deconstructs the roadblocks that are standing in the way of restoring health to thousands of 606 $aProcurement of organs, tissues, etc$xEconomic aspects$zUnited States 606 $aProcurement of organs, tissues, etc$xMoral and ethical aspects$zUnited States 606 $aTransplantation of organs, tissues, etc$xEconomic aspects$zUnited States 606 $aTransplantation of organs, tissues, etc$xMoral and ethical aspects$zUnited States 608 $aElectronic books. 615 0$aProcurement of organs, tissues, etc.$xEconomic aspects 615 0$aProcurement of organs, tissues, etc.$xMoral and ethical aspects 615 0$aTransplantation of organs, tissues, etc.$xEconomic aspects 615 0$aTransplantation of organs, tissues, etc.$xMoral and ethical aspects 676 $a617.9/54 700 $aCherry$b Mark J$0884868 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910458560203321 996 $aKidney for sale by owner$92297113 997 $aUNINA